Prophylaxis and screening options: Recommendations for young women with BRCA mutations

Breast Disease

Volumn 23, Issue , 2005, Pages 31-35

  Samuel, Jonathan C ^a   Ollila, David W ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Bilateral ovariectomy; BRCA1; BRCA2; Breast neoplasms; Genes; Magnetic resonance imaging; Mastectomy

Indexed keywords

BRCA PROTEIN; BREAST CANCER SUPPRESSOR PROTEIN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

BREAST CANCER; BREAST EXAMINATION; BREAST RECONSTRUCTION; BREAST SELF EXAMINATION; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CLINICAL EXAMINATION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; ECHOMAMMOGRAPHY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; HETEROZYGOTE DETECTION; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; LYMPHEDEMA; MAMMOGRAPHY; MASTECTOMY; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIECTOMY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; ADULT; BREAST TUMOR; GENETIC SCREENING; GENETICS; MUTATION; TUMOR SUPPRESSOR GENE;

ADULT; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC SCREENING; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASTECTOMY; MUTATION; OVARIECTOMY;

EID: 33748118733     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/bd-2006-23105     Document Type: Review

References (26)

1. J.M. Hall, M.K. Lee, B. Newman et al., Linkage of early-onset familial breast cancer to chromosome 17q21, Science 250 (1990), 1684-1689.
2. Y. Miki, J. Swensen, D. Shattuck-eidens et al., A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science 266 (1994), 66-71.
3. R. Wooster, S.L. Neuhausen, J. Mangion et al., Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13, Science 265 (1994), 2088-2090.
4. O.I. Olopade and G. Artioli, Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations, The Breast Journal 10 (2004), S5-S9.
5. J. Peto, N. Collins, R. Barfoot et al., Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer, Journal of the National Cancer Institute 91 (1999), 943-949.
6. Anglican Breast Cancer Study Group: Prevalence and Penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases, British Journal of Cancer 83 (2001), 1301-1308.
7. A. Antoniou, P.D.P. Pharoah, S. Narod et al., Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies, Am. J. Hum. Genet 72 (2003), 1117-1130.
8. US Preventive Services Task Force: Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement, Annals of Internal Medicine 143 (2005), 355-361.
9. E.J. Meijers-Heijboer, L.C. Verhoog, C.T.M. Brekelmans et al., Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation, Lancet 355 (2000), 2015-2020.
10. L. Scheuer, N. Kauff, M. Robson et al., Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers, J Clin. Onc. 20 (2002), 1260-1268.
11. S.R. Lakhani, The pathology of familial breast cancer: Morphological aspects, Breast Cancer Res 1 (1999), 31-35.
12. E. Warner, D.B. Plewes, K.A. Hill et al., Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination, JAMA 292 (2004), 1317-1325.
13. MARIBS study group: Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS), Lancet 365 (2005), 1769-1778.
14. M. Kriege, C.T.M. Brekelmans, C. Boetes et al., Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition, NEJM 351 (2004), 427-437.
15. C.D. Lehman, J.D. Blume, P. Weatherall et al., Screening women at high risk for breast cancer with mammography, Cancer 103 (2005), 1898-1905.
16. C.N. West, M.B. Barton and A.I. Liu, Bilateral prophylactic mastectomy: Complications and subsequent procedures, J Clin. Onc. 22 (2004), 6041.
17. S.L. Spear, M.E. Carter and K. Schwarz, Prophylactic mastectomy: Indications, options, and reconstructive alternatives, Plastic and Reconstructive Surgery 115 (2005), 891-909.
18. L.C. Hartmann, D.J. Schaid, J.E. Woods et al., Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer, NEJM 340 (1999), 77-84.
19. M.H. Gail, L.A. Brinton, D.P. Byar et al., Projecting individualized probabilities of developing breast cancer for white females who are being examined annually, J Natl Ca Inst 81 (1989), 1879-1876.
20. H. Meijers-Heijboer, B. Van Geel, W.L.J. van Patten et al., Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation, NEJM 345 159-164.
21. K.A. Metcalfe, M.J. Esplen, V. Goel et al., Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy, Psycho-Onc 13 (2004), 14-25.
22. M.E. Stefanek, K.J. Helzlsouer, P.M. Wilcox et al., Predictors of satisfaction with bilateral prophylactic mastectomy, Prev Med 24 (1995), 412-419.
23. M.H. Frost, D.J. Schaid, T.A. Sellers et al., Long-term satisfaction and psychological and social functioning following bilateral prophylactic mastectomy, JAMA 284 (2000), 319-324.
24. T.R. Rebbeck, A.M. Levin, A. Eisen et al., Breast cancer risk after bilateral prophylactic oopherectomy in BRCA1 mutation carriers, JNCI 91 (1999), 1475-1479.
25. N.D. Kauff, J.M. Satagopan, M.E. Robson et al., Risk-reducing salpingo-oopherectomy in women with a BRCA1 or BRCA2 mutation, NEJM 346 (2002), 1609-1615.
26. M. Robson, M. Hensley, R. Barakat et al., Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy, Gyn Onc 89 (2003), 281-287.